As more and more weight-loss startups prescribe Ozempic and Wegovy, doctors say they’re making unproven claims
Noom, Calibrate, and Embla tell customers they can stop taking GLP-1s and keep off the weight they’ve lost. Doctors and drug manufacturers disagree.
Fortune ·